Jae Myoung Noh1, Jihun Kim2, Dae Yeon Cho2, Doo Ho Choi1, Won Park1, Seung Jae Huh1. 1. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 2. LabGenomics Clinical Research Institute, LabGenomics, Seongnam, Korea.
Abstract
PURPOSE: We performed exome sequencing in a breast cancer family without BRCA mutations. MATERIALS AND METHODS: A family that three sisters have a history of breast cancer was selected for analysis. There were no family members with breast cancer in the previous generation. Genetic testing for BRCA mutation was negative, even by the multiplex ligation-dependent probe amplification method. Two sisters with breast cancer were selected as affected members, while the mother of the sisters was a non-affected member. Whole exome sequencing was performed on the HiSeq 2000 platform with paired-end reads of 101 bp in the three members. RESULTS: We identified 19,436, 19,468, and 19,345 single-nucleotide polymorphisms (SNPs) in the coding regions. Among them, 8,759, 8,789, and 8,772 were non-synonymous SNPs, respectively. After filtering out 12,843 synonymous variations and 12,105 known variations with indels found in the dbSNP135 or 1000 Genomes Project database, we selected 73 variations in the samples from the affected sisters that did not occur in the sample from the unaffected mother. Using the Sorting Intolerant From Tolerant (SIFT), PolyPhen-2, and MutationTaster algorithms to predict amino acid substitutions, the XCR1, DLL1, TH, ACCS, SPPL3, CCNF, and SRL genes were risky among all three algorithms, while definite candidate genes could not be conclusively determined. CONCLUSION: Using exome sequencing, we found 7 variants for a breast cancer family without BRCA mutations. Genetic evidence of disease association should be confirmed by future studies.
PURPOSE: We performed exome sequencing in a breast cancer family without BRCA mutations. MATERIALS AND METHODS: A family that three sisters have a history of breast cancer was selected for analysis. There were no family members with breast cancer in the previous generation. Genetic testing for BRCA mutation was negative, even by the multiplex ligation-dependent probe amplification method. Two sisters with breast cancer were selected as affected members, while the mother of the sisters was a non-affected member. Whole exome sequencing was performed on the HiSeq 2000 platform with paired-end reads of 101 bp in the three members. RESULTS: We identified 19,436, 19,468, and 19,345 single-nucleotide polymorphisms (SNPs) in the coding regions. Among them, 8,759, 8,789, and 8,772 were non-synonymous SNPs, respectively. After filtering out 12,843 synonymous variations and 12,105 known variations with indels found in the dbSNP135 or 1000 Genomes Project database, we selected 73 variations in the samples from the affected sisters that did not occur in the sample from the unaffected mother. Using the Sorting Intolerant From Tolerant (SIFT), PolyPhen-2, and MutationTaster algorithms to predict amino acid substitutions, the XCR1, DLL1, TH, ACCS, SPPL3, CCNF, and SRL genes were risky among all three algorithms, while definite candidate genes could not be conclusively determined. CONCLUSION: Using exome sequencing, we found 7 variants for a breast cancer family without BRCA mutations. Genetic evidence of disease association should be confirmed by future studies.
Authors: Henry Lynch; Hongxiu Wen; Yeong C Kim; Carrie Snyder; Yulia Kinarsky; Pei Xian Chen; Fengxia Xiao; David Goldgar; Kenneth H Cowan; San Ming Wang Journal: Breast J Date: 2013-06-26 Impact factor: 2.431
Authors: Jin Ho Kim; Doo Ho Choi; Dae Yeon Cho; Sei Hyun Ahn; Byung Ho Son; Bruce G Haffty Journal: Breast Cancer Res Treat Date: 2010-03-06 Impact factor: 4.872
Authors: Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding Journal: Science Date: 1994-10-07 Impact factor: 47.728
Authors: Doo Ho Choi; Dae Yeon Cho; Min Hyuk Lee; Hee Sook Park; Sei Hyun Ahn; Byung Ho Son; Bruce G Haffty Journal: Breast Cancer Res Treat Date: 2008-01-03 Impact factor: 4.872
Authors: Sang-Ah Han; Sung-Won Kim; Eunyoung Kang; Sue K Park; Sei-Hyun Ahn; Min Hyuk Lee; Seok-Jin Nam; Wonshik Han; Young Tae Bae; Hyun-Ah Kim; Young Up Cho; Myung Chul Chang; Nam Sun Paik; Ki-Tae Hwang; Sei Joong Kim; Dong-Young Noh; Doo Ho Choi; Woo-Chul Noh; Lee Su Kim; Ku Sang Kim; Young Jin Suh; Jeong Eon Lee; Yongsik Jung; Byung-In Moon; Jung-Hyun Yang; Byung Ho Son; Cha Kyong Yom; Sung Yong Kim; Hyde Lee; Sung Hoo Jung Journal: Fam Cancer Date: 2013-03 Impact factor: 2.375
Authors: Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder Journal: Nature Date: 2007-06-28 Impact factor: 49.962
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254
Authors: Eunjin Jwa; Kyung Hwan Shin; Ja Young Kim; Young Hee Park; So-Youn Jung; Eun Sook Lee; In Hae Park; Keun Seok Lee; Jungsil Ro; Yeon-Joo Kim; Tae Hyun Kim Journal: Cancer Res Treat Date: 2016-02-18 Impact factor: 4.679
Authors: Duna H Barakeh; Rasha Aljelaify; Yara Bashawri; Amal Almutairi; Fatimah Alqubaishi; Mohammed Alnamnakani; Latifa Almubarak; Abdulrahman Al Naeem; Fatema Almushawah; May Alrashed; Malak Abedalthagafi Journal: Oncotarget Date: 2021-03-30
Authors: Giovana T Torrezan; Fernanda G Dos Santos R de Almeida; Márcia C P Figueiredo; Bruna D de Figueiredo Barros; Cláudia A A de Paula; Renan Valieris; Jorge E S de Souza; Rodrigo F Ramalho; Felipe C C da Silva; Elisa N Ferreira; Amanda F de Nóbrega; Paula S Felicio; Maria I Achatz; Sandro J de Souza; Edenir I Palmero; Dirce M Carraro Journal: Front Genet Date: 2018-05-07 Impact factor: 4.599